What is MassTech?
MassTech Inc. is a key player in the scientific and pharmaceutical industries, specializing in the development and application of advanced AP-MALDI mass spectrometry technology. Their product portfolio, including the MT Explorer 30 and various AP/MALDI ion sources, is designed to enhance mass spectrometry capabilities for clients engaged in drug discovery and related research. The company's commitment to innovation is evident in their user-friendly designs and active participation in industry events, where they showcase their cutting-edge solutions and provide expert consultations.
How much funding has MassTech raised?
MassTech has raised a total of $309K across 2 funding rounds:
Debt
$150K
Debt
$159K
Debt (2020): $150K with participation from PPP
Debt (2021): $159K led by PPP
Key Investors in MassTech
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for MassTech?
With a large-scale, late-stage funding round, MassTech is poised for significant scaling and market penetration. The recent strategic investment suggests a focus on accelerating product development, expanding operational capacity, and potentially entering new market segments. This capital infusion will likely empower MassTech to further solidify its leadership in mass spectrometry technology, driving innovation in scientific and pharmaceutical research and development.
See full MassTech company page
